← Back to KYNB

Kyntra Bio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 12/05/2025
−$1.5$3.7$1.1$1.3$2.7$0.1$1$25
$12−$15$201−$7.6$4.6−$17−$16−$33
$2.96−$3.76$49.61−$1.88$1.15−$4.25−$3.89−$0.33
444499

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.